Faecal Extraction Systems Market Overview, Analysis And Demand By 2034

Claim 20% Off With Code ONLINE20 – Explore Market Reports Covering Trade Trends, Regulatory Changes, and Growth Insights

What Is the Potential Market Growth Rate of the Faecal Extraction Systems Market?
The faecal extraction systems market size has grown steadily in recent years. It will grow from $1.66 billion in 2024 to $1.7 billion in 2025 at a compound annual growth rate (CAGR) of 2.5%. The growth in the historic period can be attributed to ethical concerns and stringent regulations, economic conditions, disruption in research activities, impact of COVID-19, increased prevalence of inflammatory bowel disease (IBD).

The faecal extraction systems market size is expected to see strong growth in the next few years. It will grow to $2.1 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to sustainable recovery, regional dominance, government support and research investments, post-covid recovery. Major trends in the forecast period include product innovations, marketing strategies and channels, market players, economic conditions, technological innovations.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8297&type=smp

Who Are the Major Contributors to the Faecal Extraction Systems Market Growth?
The increasing prevalence of inflammatory bowel disease is expected to propel the growth of the faecal extraction systems market going forward. Inflammatory bowel disease (IBD) is a category of illnesses characterized by long-term (chronic) inflammation of digestive system tissues. Faecal extraction systems are used for the diagnosis, monitoring of disease activity, treatment guidance, and prediction of disease relapse and post-operative recurrence in inflammatory bowel disease, as a result, the increasing prevalence of inflammatory bowel disease increases the demand for faecal extraction systems. For instance, in September 2023, according to the Impact of IBD Report 2023 published by the IBD Clinical and Research Centre, a Canada-based organization that aims to improve the lives of patients with Crohn's disease and ulcerative colitis, with a prevalence of 825 per 100,000 in 2023, over 320,000 people in Canada have inflammatory bowel disease (IBD), and as the prevalence is expected to increase by 2.44% annually, 1.1% of the population, or 470,000 Canadians, is projected to be living with IBD by 2035. Therefore, the increasing prevalence of inflammatory bowel disease in faecal extraction systems is expected drives the growth of the faecal extraction systems market.

What Are the Key Segments in the Faecal Extraction Systems Market?
The faecal extraction systemsmarket covered in this report is segmented –

1) By Assay: Calprotectin, Albumin, Hemoglobin, Bile Acids
2) By Analysis Test: Microscopic, Chemical, Immunological, Microbiological
3) By Indication: Parasitic Infection, Viral Infection, Bacterial Indication, Poor Nutrient Absorption
4) By End-Use: Diagnostic Centers, Hospitals And Clinics, Ambulatory Clinics, Research Centers

Subsegments:
1) By Calprotectin: Quantitative Calprotectin Assays, Qualitative Calprotectin Assays
2) By Albumin: Fecal Albumin Assays, Albumin-To-Creatinine Ratio Assays
3) By Hemoglobin: Fecal Occult Blood Tests (FOBT), Immunochemical Fecal Hemoglobin Tests
4) By Bile Acids: Fecal Bile Acid Assays, Bile Acid Malabsorption Tests

What Are the Future Trends Forecasted for the Faecal Extraction Systems Market?
Major companies operating in the faecal extraction system market are developing innovative products such as fecal DNA tests to meet larger customer bases, more sales, and increase revenue. Fecal DNA tests refer to non-invasive diagnostic procedures that analyze DNA extracted from a person's stool sample. For instance, in March 2023, BGI Genomics, a China-based biotechnology company, together with Zentya, a Slovakia-based prominent provider in the field of genetic screening, launched COLOTECT 1.0. Distinguishing itself as one of the pioneering fecal DNA tests for colorectal cancer in Slovakia, COLOTECT 1.0 stands out for its non-invasive nature and ability to detect colorectal cancer and precancerous lesions. The test employs multiplex methylation-specific PCR technology, enabling the identification of abnormal colorectal cancer DNA-methylation biomarkers from fecal samples.

Who Are the Prominent Players in theFaecal Extraction Systems Market?
Major companies operating in the faecal extraction systems market are Alpha Laboratories Ltd., Arbor Assays, bioMérieux SA, Buhlmann Laboratories AG, Calpro AS, DRG Instruments GmbH, Promega Corporation, Werfen SA, Mobidiag Oy, Biohit Healthcare Ltd., Meridian Bioscience Inc., Quidel Corporation, DiaSorin SpA, Sekisui Diagnostics LLC, Hologic Inc., Abbott Laboratories, Roche Diagnostics Corporation, Siemens Healthineers, Beckman Coulter Inc., Cepheid Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, Luminex Corporation, QIAGEN NV, Quest Diagnostics Incorporated, Randox Laboratories Ltd., Thermo Fisher Scientific Inc., Trinity Biotech plc

Get the full faecal extraction systems market report here:
https://www.thebusinessresearchcompany.com/report/faecal-extraction-systems-global-market-report

Which Regions Are Forecasted to Experience the Fastest Growth in the Faecal Extraction Systems Market?
North America was the largest region in the faecal extraction systems market in 2024. The regions covered in the faecal extraction systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company